Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of acetazolamide in the management of diuretic resistance.

Proceedings (Baylor University. Medical Center)·2021
Same author

Evaluation of medication compliance for secondary prevention of acute coronary syndrome.

Proceedings (Baylor University. Medical Center)·2017
Same author

Gemcitabine associated pseudocellulitis: A missed diagnosis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2017
Same author

Takotsubo cardiomyopathy with Guillain-Barré syndrome.

Proceedings (Baylor University. Medical Center)·2017
Same author

Case report: Cocaine-induced takotsubo cardiomyopathy.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2017
Same author

Consideration of alternative causes of lactic acidosis: Thiamine deficiency in malignancy.

The American journal of emergency medicine·2017

Related Experiment Video

Updated: Apr 21, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K

Re-inventing clinical trials through TransCelerate.

Dalvir Gill1

  • 1TransCelerate BioPharma, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, USA.

Nature Reviews. Drug Discovery
|November 1, 2014
PubMed
Summary
This summary is machine-generated.

TransCelerate BioPharma, a non-profit, collaborates to improve drug development. They aim to deliver new medicines efficiently, effectively, and with high quality.

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Related Experiment Videos

Last Updated: Apr 21, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Area of Science:

  • Biopharmaceutical Research and Development
  • Drug Discovery and Delivery
  • Clinical Trials and Medicine Development

Background:

  • The biopharmaceutical industry faces challenges in delivering new medicines efficiently.
  • Collaboration is crucial for addressing complex R&D hurdles.
  • A need exists for streamlined processes in drug development.

Purpose of the Study:

  • To outline the mission and collaborative approach of TransCelerate BioPharma.
  • To highlight the organization's role in improving medicine delivery.
  • To establish a framework for efficient and effective biopharmaceutical R&D.

Main Methods:

  • Formation of a non-profit organization in 2012.
  • Cross-industry collaboration among biopharmaceutical stakeholders.
  • Identification, prioritization, and design of R&D solutions.

Main Results:

  • Established a collaborative platform for biopharmaceutical R&D.
  • Initiated the implementation of solutions for efficient drug delivery.
  • Fostered an environment for high-quality medicine development.

Conclusions:

  • TransCelerate BioPharma's collaborative model drives efficiency in medicine delivery.
  • The organization facilitates the implementation of impactful R&D solutions.
  • Effective collaboration is key to advancing biopharmaceutical innovation and patient access.